FDA Inspection 1297946 — ImpactLife
The FDA completed an inspection of ImpactLife on Dec 22, 2025 in Fairview Heights, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fairview Heights, IL (United States)